Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder

Xavier Benarous, Vladimir Ferrafiat, Jessica Zammit, Angèle Consoli, Priscille Gérardin, Jean Marc Guilé, David Cohen

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish
Pages (from-to)455-457
Number of pages3
JournalCNS Spectrums
Issue number4
StatePublished - 1 Aug 2020
Externally publishedYes


  • Atomoxetine
  • Chronic irritability
  • Depressive Disorders
  • Disruptive Mood Dysregulation Disorder
  • Inhibitor of the norepinephrine transporter

Cite this